MAMLD1 is an X-linked transcriptional co-activator that plays a critical role in male sex development and testicular function. Functionally, MAMLD1 transactivates the HES3 promoter independently of canonical NOTCH signaling, localizing to nuclear bodies without demonstrable DNA-binding capacity 1. During fetal development, MAMLD1 is expressed in Sertoli and Leydig cells around the critical period for sex development, where it regulates testosterone production by enhancing CYP17A1 expression and 17α-hydroxylation 2. MAMLD1 is regulated by steroidogenic factor 1 (SF1), integrating into the molecular network governing fetal testosterone synthesis 1. Pathogenic MAMLD1 variants cause 46,XY differences/disorders of sex development (DSD), with hypospadias as the primary clinical phenotype, presenting as a continuous spectrum from micropenis to complete gonadal dysplasia 3. However, MAMLD1 variants alone may be insufficient to explain DSD phenotypes, suggesting oligogenic inheritance 4. Beyond reproductive development, MAMLD1 is overexpressed in ACTH-secreting pituitary adenomas (Cushing's disease) 5 and serves as a diagnostic biomarker for polycystic ovary syndrome and recurrent implantation failure 6. Additionally, YAP-MAMLD1 fusion proteins drive ependymoma development through liquid-liquid phase separation, forming nuclear condensates that concentrate oncogenic transcriptional co-activators 7.